ProCore Bio Med

ProCore Bio Med Overview

ProCore Bio Med is a biotechnology company developing cost-effective solutions with a focus on bone and cartilage regeneration, integrating proprietary scaffolds, growth factors, and stem or progenitor cells. The companys technology platform includes a variety of biomaterials useful for multiple clinical applications, in particular hyaluronic acid-based injectable hydrogels; a set of proprietary growth factors with enhanced activity, selectivity, and stability; and protocols for stem and progenitor cell isolation, expansion, and differentiation. ProCores RegenoGel is a highly stable viscosupplement gel for treating osteoarthritis to preserve joints and regenerate cartilage. RegenoGel is based on the companys proprietary HAProLink, which joins a high-molecular-weight HA with a regenerative fibrinogen matrix. ProCore has been a principal member of the Genesis consortium, the Israeli consortium for stem cell therapy. Procore was acknowledged for its contributions to the consortium, including allowing access to its proprietary set of FGF variants, as well as for its unique stem cell platform and the development of a novel antibody microarray for stem cell characterization.

Latest News

No news articles.

Funding

Team Members

1

Employees: 1-10

Web & Social Links

Locations

Golda Me'ir Street 7, Nes Ziyyona, Israel

Photos & Videos

2 item(s)

ProCore Bio Med Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info